| Wikileaks: Big Pharma Inside
The World Health Organization
Wikileaks released a confidential pharmaceutical industry trade
association dossier about the WHO Expert Working Group (EWG) on
R&D Financing.
The International Federation of Pharmaceutical Manufacturers
& Associations (IFPMA; "Big Pharma") gave its members
4 documents: a non-public draft report of the WHO EWG and a non-public
Comparative Analysis done by the working group, the IFPMA Overview
of the EWG Comparative Analysis, and IFPMA summary slide on the
EWG Draft Report.
The compilation of documents shows the influence of "Big
Pharma" on the policy making decisions of the WHO, the UN
body safeguarding public health. These confidential documents
were obtained by the drug industry before their public release
to WHO member states (scheduled to be released May 2010). The
document also illustrates that the WHO expert group was highly
responsive to industry lobbying — a result that public health
groups had feared since early 2009, when the expert group met
with the industry, but refused to meet with public health groups
known to be industry critics.
The likely audience for these documents include countries, public
health policy makers, civil society, industry, academia, media,
patients and the general public.
Journalists can contact Dr Margaret Chan, Director-General of
WHO: chanm@who.int and Malebona Precious Matsoso, WHO Director,
Public Health, Innovation and Intellectual Property: matsosom@who.int
According to our source, the English version of the final report
of the EWG with its recommendations is expected to be released
to member state countries this week.
Contents
* ewg-comparative-analysis-11-12-09.pdf
* ewg-report-draft-20-11-09.pdf
* ifpma-ewg-final-report-draft.pdf
* ifpma-ewg-internal-mail.pdf
* ifpma-ewg-overview-comparative-analysis.pdf
Reference Source: wikileaks.com
December 10, 2009
 ...............................................................................................................
|
